<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ten patients with the <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (eight with <z:hpo ids='HP_0001903'>anemia</z:hpo>, two with <z:hpo ids='HP_0001913'>granulocytopenia</z:hpo>, four with <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>) were given <z:chebi fb="0" ids="4913">etretinate</z:chebi> (ER) and <z:chebi fb="0" ids="26537">retinoid</z:chebi> acid (RA) </plain></SENT>
<SENT sid="1" pm="."><plain>No correlation was seen between the RA effect in vitro and its clinical effect </plain></SENT>
<SENT sid="2" pm="."><plain>No effect was seen of the ER-treatment or of the RA-treatment on <z:hpo ids='HP_0001903'>anemia</z:hpo>, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> or the abnormal karyotype seen in three patients </plain></SENT>
<SENT sid="3" pm="."><plain>In three of eight patients given RA a decreased blast cell percentage in the bone marrow was seen, and in two of these there was also a normalization of the in vitro bone marrow cell colony formation </plain></SENT>
<SENT sid="4" pm="."><plain>We found no clinical effect of ER and only a minimal one of RA </plain></SENT>
</text></document>